Furthermore, we observed that the deletion of SARM1 in 8-month-old, rather than 3-month-old APP/PS1 mice ameliorated disease progression of AD as evidenced by behavioral and histological tests (Fig. 2, 3, 4, and Supplementary Fig. 2). Here, SARM1 is linked to Alzheimer disease.